Eva Genel is the new Director of Research and Development, Skincare at Silk Therapeutics Inc., a specialty biomaterials company.

In this new role, Genel's key responsibilities include designing and assessing clean, skincare formulations, overseeing testing, while spearheading innovation, and product development. Genel relocated from Paris, France and is now based in the company's Medford, MA, headquarters, reporting to Greg Altman, CEO of Silk Therapeutics.

Genel has more than 15 years of skincare and ingredient-testing experience. She most recently served as the director of formulation and development at Groupe Rocher. Here, she led formulation and development across a team of 50 scientists for Yves Rocher, a botanical-based cosmetic brand in France.

Genel earned a double degree; a Master of Engineering from Ecole Centrale in Paris and a Master of Science in Pharmaceutical Engineering from Columbia University in New York City.